Key result
Positron emission tomography (PET) imaging demonstrates value in the diagnosis of coronary artery disease, management of complex endocarditis, and targeted cardiovascular therapies.
Why the study?
Cardiovascular disease management has historically relied on structural and anatomical imaging, but there is an increasing shift toward functional imaging studies such as PET.
PET imaging serves as a valuable noninvasive functional imaging tool for cardiac surgeons in the diagnosis and management of complex heart diseases.
May support PET as noninvasive tool for cardiac surgeons in CAD and endocarditis; leaves open need for prospective validation.
Historically, structural and anatomical imaging has been the mainstay in the diagnosis and management of cardiovascular diseases. In recent years there has been a shift toward increased use of functional imaging studies, including positron emission tomography (PET). PET is a noninvasive nuclear medicine-imaging technique that uses radiotracers to generate images of a radionucleotide distribution by detecting the physiologic substrates that emit positron radionuclides. This article will focus on the applications of PET imaging for the cardiac surgeon and highlight the collaborative nature of using PET imaging for the management of complex heart disease. We present cases that demonstrate the value of using PET imaging in the diagnosis of coronary artery disease and management of complex endocarditis, and in targeted cardiovascular therapies.
No takes yet. Share an insight, caveat, or question.
Williams et al. (2022) conducted a review in Cardiovascular diseases. Positron emission tomography (PET) imaging was evaluated. Positron emission tomography (PET) imaging demonstrates value in the diagnosis of coronary artery disease, management of complex endocarditis, and targeted cardiovascular therapies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: